213 related articles for article (PubMed ID: 36657993)
1. CAR-T Cell-Mediated B-Cell Depletion in Central Nervous System Autoimmunity.
Gupta S; Simic M; Sagan SA; Shepherd C; Duecker J; Sobel RA; Dandekar R; Wu GF; Wu W; Pak JE; Hauser SL; Lim W; Wilson MR; Zamvil SS
Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36657993
[TBL] [Abstract][Full Text] [Related]
2. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
Weber MS; Prod'homme T; Patarroyo JC; Molnarfi N; Karnezis T; Lehmann-Horn K; Danilenko DM; Eastham-Anderson J; Slavin AJ; Linington C; Bernard CC; Martin F; Zamvil SS
Ann Neurol; 2010 Sep; 68(3):369-83. PubMed ID: 20641064
[TBL] [Abstract][Full Text] [Related]
3. α4-integrin deficiency in B cells does not affect disease in a T-cell-mediated EAE disease model.
Hussain RZ; Cravens PD; Miller-Little WA; Doelger R; Granados V; Herndon E; Okuda DT; Eagar TN; Stüve O
Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e563. PubMed ID: 31086806
[TBL] [Abstract][Full Text] [Related]
4. Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis.
Tacke S; Chunder R; Schropp V; Urich E; Kuerten S
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328594
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice.
Pol S; Liang S; Schweser F; Dhanraj R; Schubart A; Preda M; Sveinsson M; Ramasamy DP; Dwyer MG; Weckbecker G; Zivadinov R
Exp Neurol; 2021 Jan; 335():113488. PubMed ID: 32991933
[TBL] [Abstract][Full Text] [Related]
6. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Chen D; Ireland SJ; Davis LS; Kong X; Stowe AM; Wang Y; White WI; Herbst R; Monson NL
J Immunol; 2016 Feb; 196(4):1541-9. PubMed ID: 26764035
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
[TBL] [Abstract][Full Text] [Related]
8. Development of a CD19 PET tracer for detecting B cells in a mouse model of multiple sclerosis.
Stevens MY; Cropper HC; Lucot KL; Chaney AM; Lechtenberg KJ; Jackson IM; Buckwalter MS; James ML
J Neuroinflammation; 2020 Sep; 17(1):275. PubMed ID: 32948198
[TBL] [Abstract][Full Text] [Related]
9. CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS.
Kumar G; Maria Z; Kohli U; Agasing A; Quinn JL; Ko RM; Zamvil SS; Axtell RC
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33649164
[TBL] [Abstract][Full Text] [Related]
10. Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.
Martinez-Pasamar S; Abad E; Moreno B; Velez de Mendizabal N; Martinez-Forero I; Garcia-Ojalvo J; Villoslada P
BMC Syst Biol; 2013 Apr; 7():34. PubMed ID: 23618467
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders.
Lehmann-Horn K; Schleich E; Hertzenberg D; Hapfelmeier A; Kümpfel T; von Bubnoff N; Hohlfeld R; Berthele A; Hemmer B; Weber MS
J Neuroinflammation; 2011 Oct; 8():146. PubMed ID: 22027448
[TBL] [Abstract][Full Text] [Related]
12. B cells are required for sunlight protection of mice from a CNS-targeted autoimmune attack.
Kok LF; Marsh-Wakefield F; Marshall JE; Gillis C; Halliday GM; Byrne SN
J Autoimmun; 2016 Sep; 73():10-23. PubMed ID: 27289166
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
[TBL] [Abstract][Full Text] [Related]
14. Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
Migotto MA; Mardon K; Orian J; Weckbecker G; Kneuer R; Bhalla R; Reutens DC
Front Immunol; 2019; 10():2437. PubMed ID: 31681317
[No Abstract] [Full Text] [Related]
15. Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis.
Avouac J; Cauvet A; Orvain C; Boulch M; Tilotta F; Tu L; Thuillet R; Ottaviani M; Guignabert C; Bousso P; Allanore Y
Arthritis Rheumatol; 2024 Feb; 76(2):268-278. PubMed ID: 37610259
[TBL] [Abstract][Full Text] [Related]
16. T Cell Delivery of Nanoparticles-Bound Anti-CD20 Monoclonal Antibody: Successful B Cell Depletion in the Spinal Cord during Experimental Autoimmune Encephalomyelitis.
Carnasciali A; Amoriello R; Bonechi E; Mazzoni A; Ravagli C; Doumett S; Cappiello L; D'Elios MM; Baldi G; Ballerini C
J Neuroimmune Pharmacol; 2021 Jun; 16(2):376-389. PubMed ID: 32514635
[TBL] [Abstract][Full Text] [Related]
17. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity.
Prado C; Osorio-Barrios F; Falcón P; Espinoza A; Saez JJ; Yuseff MI; Pacheco R
J Neuroinflammation; 2021 Dec; 18(1):292. PubMed ID: 34920747
[TBL] [Abstract][Full Text] [Related]
19. The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis.
Cravens PD; Kieseier BC; Hussain R; Herndon E; Arellano B; Ben LH; Timmons BC; Castro-Rojas C; Hartung HP; Hemmer B; Weber MS; Zamvil SS; Stüve O
J Neuroinflammation; 2013 May; 10():67. PubMed ID: 23705890
[TBL] [Abstract][Full Text] [Related]
20. MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
Molnarfi N; Schulze-Topphoff U; Weber MS; Patarroyo JC; Prod'homme T; Varrin-Doyer M; Shetty A; Linington C; Slavin AJ; Hidalgo J; Jenne DE; Wekerle H; Sobel RA; Bernard CC; Shlomchik MJ; Zamvil SS
J Exp Med; 2013 Dec; 210(13):2921-37. PubMed ID: 24323356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
